← Back to Search

Virtual PREHAB for Cardiovascular Disease

N/A
Recruiting
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Severe functional limitations
Cognitive impairment that impacts consenting ability
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-months postoperatively
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study the effectiveness and safety of providing virtual preoperative cardiac rehabilitation (PREHAB) to frail patients before they undergo transcatheter aortic valve implantation (TAVI)

Who is the study for?
This trial is for outpatients in Nova Scotia who are frail and awaiting a less invasive heart valve surgery called TAVI. They must be able to give informed consent. It's not clear who can't join because the exclusion criteria aren't listed.
What is being tested?
The study tests if virtual PREHAB (preoperative cardiac rehabilitation) at home can improve health before TAVI, compared to standard care. Healthcare providers deliver this program virtually to see if it helps reduce frailty safely and feasibly.
What are the potential side effects?
Since the intervention involves non-invasive prehabilitation exercises and nutritional guidance delivered virtually, side effects may include typical exercise-related issues like muscle soreness or fatigue.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe difficulties performing daily activities.
Select...
I can make decisions about my health care.
Select...
My heart condition severely limits my physical activity.
Select...
I don't have internet or phone access for virtual health programs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-months postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-months postoperatively for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
CLSA-FI
PFFS-FI
Secondary study objectives
Cardiac rehabilitation attendance
EQ-5D-5L health-related quality of life
VARC-3 Composite clinical end-points

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual PREHABExperimental Treatment1 Intervention
In addition to standard care, participants randomized to the The virtual PREHAB program will be delivered by the Hearts and Health in Motion cardiac rehabilitation CR health care team including a medical director nurse, dietician, and physiotherapist who routinely deliver CR postoperatively. The virtual PREHAB program will be up to 8-weeks in duration and deliver the core components of CR online or by telephone.
Group II: Standard CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Nova Scotia Health AuthorityLead Sponsor
288 Previous Clinical Trials
94,522 Total Patients Enrolled
3 Trials studying Frailty
498 Patients Enrolled for Frailty
~5 spots leftby Mar 2025